Cargando…
Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
Colorectal cancer (CRC) is one of the leading causes of cancer deaths worldwide. Recent advances in recombinant DNA technology have led to the development of numerous therapeutic antibodies as major sources of blockbuster drugs for CRC therapy. Simultaneously, increasing numbers of therapeutic targe...
Autores principales: | Hwang, Kyusang, Yoon, Jin Hwan, Lee, Ji Hyun, Lee, Sukmook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824816/ https://www.ncbi.nlm.nih.gov/pubmed/33466394 http://dx.doi.org/10.3390/biomedicines9010039 |
Ejemplares similares
-
TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy
por: Heo, Kyun, et al.
Publicado: (2020) -
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
por: Kim, Ji Woong, et al.
Publicado: (2021) -
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
por: Kong, Deok-Hoon, et al.
Publicado: (2017) -
Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
por: Akbarzadeh Khiavi, Mostafa, et al.
Publicado: (2019) -
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
por: Kim, Ji Woong, et al.
Publicado: (2021)